Written by Rohan Narayanan on September 15, 2022
C-Path, NORD and FDA hosted an annual workshop September 13-14 to spotlight the impact of their innovative data and analytics platform on rare disease drug development
TUCSON, Ariz. and WASHINGTON, DC, September 15, 2022 — The Rare Disease Cures Accelerator-Data and Analytics Platform initiative (RDCA-DAP®) Read More
Written by Valaree DonFrancesco on September 13, 2022
Registration is OPEN for the 2022 RDCA-DAP Workshop! Join us this September as we bring rare disease stakeholders together for next-level platform demonstrations and case studies, industry expert presentations, panel discussions, and more.
Register here: bit.ly/2022_NORD_RDCA-DAP_Workshop
Attendees of the 1.5-day workshop, including patients, providers, researchers, clinicians, biopharmaceutical companies, regulatory reviewers, and… Read More
Written by Rohan Narayanan on August 25, 2022
C-Path, NORD and FDA to host annual workshop September 13-14 to highlight the impact of their innovative data and analytics platform on rare disease drug development
TUCSON, Ariz. and WASHINGTON, DC, August 25, 2022 — The Rare Disease Cures Accelerator-Data and Analytics Platform initiative (RDCA-DAP®) will host its… Read More
Written by Mary Dunkle on July 7, 2022
Explore the five steps in drug development and discover new opportunities to get involved
More than 95% of rare disease patients lack an FDA-approved treatment for their condition. However, today there are more opportunities than ever before for patients, caregivers and patient organizations to play a key role in advancing R&D… Read More
Written by Maia Craig on December 17, 2021
NORD, in partnership with the Critical Path Institute (C-Path) is proud to announce a two-part video series on patient-focused drug development (PFDD) as part of our Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP) initiative.
The first video, What is Patient-Focused Drug Development (PFDD)?, provides a brief explanation of… Read More